A

Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians

JAMA Network Open, vol. 4, pp. e2116009

Abstract

Importance: How patients with atrial fibrillation (AF) and their clinicians consider cost in forming care plans remains unknown. Objective: To identify factors that inform conversations regarding costs of anticoagulants for treatment of AF between patients and clinicians and outcomes associated with these conversations. Design, Setting, and Participants: This cohort study of recorded encounters and participant surveys at 5 US medical centers (including academic, community, and safety-net centers) from the SDM4AFib randomized trial compared standard AF care with and without use of a shared decision-making (SDM) tool. Included patients were considering anticoagulation treatment and were recruited by their clinicians between January 30, 2017, and June 27, 2019. Data were analyzed between August and November 2019. Main Outcomes and Measures: The incidence of and factors associated with cost conversations, and the association of cost conversations with patients' consideration of treatment cost burden and their choice of anticoagulation. Results: A total of 830 encounters (out of 922 enrolled participants) were recorded. Patients' mean (SD) age was 71.0 (10.4) years; 511 patients (61.6%) were men, 704 (86.0%) were White, 303 (40.9%) earned between $40 000 and $99 999 in annual income, and 657 (79.2%) were receiving anticoagulants. Clinicians' mean (SD) age was 44.8 (13.2) years; 75 clinicians (53.2%) were men, and 111 (76%) practiced as physicians, with approximately half (69 [48.9%]) specializing in either internal medicine or cardiology. Cost conversations occurred in 639 encounters (77.0%) and were more likely in the SDM arm (378 [90%] vs 261 [64%]; OR, 9.69; 95% CI, 5.77-16.29). In multivariable analysis, cost conversations were more likely to occur with female clinicians (66 [47%]; OR, 2.85; 95% CI, 1.21-6.71); consultants vs in-training clinicians (113 [75%]; OR, 4.0; 95% CI, 1.4-11.1); clinicians practicing family medicine (24 [16%]; OR, 12.12; 95% CI, 2.75-53.38]), internal medicine (35 [23%]; OR, 3.82; 95% CI, 1.25-11.70), or other clinicians (21 [14%]; OR, 4.90; 95% CI, 1.32-18.16) when compared with cardiologists; and for patients with an annual household income between $40 000 and $99 999 (249 [82.2%]; OR, 1.86; 95% CI, 1.05-3.29) compared with income below $40 000 or above $99 999. More patients who had cost conversations reported cost as a factor in their decision (244 [89.1%] vs 327 [69.0%]; OR 3.66; 95% CI, 2.43-5.50), but cost conversations were not associated with the choice of anticoagulation agent. Conclusions and Relevance: Cost conversations were common, particularly for middle-income patients and with female and consultant-level primary care clinicians, as well as in encounters using an SDM tool; they were associated with patients' consideration of treatment cost burden but not final treatment choice. With increasing costs of care passed on to patients, these findings can inform efforts to promote cost conversations in practice. Trial Registration: ClinicalTrials.gov Identifier: NCT02905032.

Authors 54

  1. Mayo Clinic

    Affiliation as printed

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

    Robert D. and Patricia E. Kern Center for the Science of HealthCare Delivery, Mayo Clinic, Rochester, Minnesota

  2. Mayo Clinic

    Affiliation as printed

    Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota

    Robert D. and Patricia E. Kern Center for the Science of HealthCare Delivery, Mayo Clinic, Rochester, Minnesota

  3. Mayo Clinic · Leiden University Medical Center

    Affiliation as printed

    Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

  4. Mayo Clinic · Colorado School of Public Health · University of Colorado Anschutz · University of Colorado Denver

    Affiliation as printed

    Colorado School of Public Health, Anschutz Medical Campus, University of Colorado, Denver, Aurora

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

  5. Mayo Clinic

    Affiliation as printed

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

  6. Mayo Clinic

    Affiliation as printed

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

  7. Mayo Clinic

    Affiliation as printed

    Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota

  8. University of Alabama at Birmingham

    Affiliation as printed

    Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham

  9. Affiliation as printed

    Division of General Internal Medicine, Hennepin Health, Minneapolis, Minnesota

  10. Mayo Clinic

    Affiliation as printed

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

    Robert D. and Patricia E. Kern Center for the Science of HealthCare Delivery, Mayo Clinic, Rochester, Minnesota

  11. Stanford Medicine · Stanford University

    Affiliation as printed

    Stanford Internal Medicine Residency Program, California

  12. Mayo Clinic

    Affiliation as printed

    Robert D. and Patricia E. Kern Center for the Science of HealthCare Delivery, Mayo Clinic, Rochester, Minnesota

  13. Mayo Clinic

    Affiliation as printed

    Heart Rhythm Services, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota

    Robert D. and Patricia E. Kern Center for the Science of HealthCare Delivery, Mayo Clinic, Rochester, Minnesota

  14. Mayo Clinic

    Affiliation as printed

    Department of Endocrinology, Mayo Clinic, Rochester, Minnesota

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

  15. Juan Pablo Brito corresponding

    Mayo Clinic

    Affiliation as printed

    Department of Endocrinology, Mayo Clinic, Rochester, Minnesota

    Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota

  16. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  17. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  18. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  19. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  20. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  21. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  22. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  23. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  24. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  25. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  26. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  27. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  28. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  29. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  30. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  31. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  32. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  33. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  34. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  35. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  36. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  37. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  38. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  39. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  40. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  41. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  42. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  43. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  44. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  45. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  46. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  47. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  48. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  49. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  50. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  51. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  52. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  53. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

  54. Affiliation as printed

    for the Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators

Cited by 21 stored of 21

No patents citing this paper on Lens.org (checked 2026-10-11).

References 36